HK Stock MarketDetailed Quotes

09960 KINDSTAR GLOBAL

Watchlist
  • 1.540
  • +0.010+0.65%
Market Closed Apr 19 16:08 CST
1.52BMarket Cap33.48P/E (TTM)

About KINDSTAR GLOBAL Company

Kangsheng Global Genetic Technology Co., Ltd. (hereinafter referred to as “Kangsheng Global”) is a large-scale high-end medical specialist examination service testing group in China. It is committed to leading the advancement of specialized medical examination technology and services in China and promoting the development and improvement of specialist diagnosis and treatment and personalized medicine in China. Based on the purpose of putting patients' interests first and doctors' needs first, Kangsheng Global follows international norms, standards and industry guidelines, introduces and develops the world's advanced technology and specialist examination methods, and provides comprehensive, advanced and accurate specialist examination services to major tertiary hospitals, specialist hospitals and general hospitals in China. Kangsheng Global has built 38,000-square-meter clinical testing, scientific research cooperation and application R&D laboratories with international advanced standards in Beijing, Shanghai, Wuhan, Xinjiang, Chengdu and Tianjin. It has high-resolution flow (FCM) testing platforms, PCR (real-time PCR) platforms, gene chip platforms (Affymetrix), liquid chip platforms (Luminex), DNA mass spectrometry platforms (Sequenom), digital gene platforms (nanoStrings), sequencing platforms, cytogenetic platforms (chromosome karyotype analysis, FISH, etc.), more than a dozen specialized laboratories, including mass spectrometry platforms, clinical pathology platforms, clinical immunization platforms, clinical chemistry platforms, etc., provided medical research, drug testing and translational medicine to clinicians across the country, to more than 3,000 hospitals in 31 provincial municipalities and 600 cities, especially more than 1,000 large tertiary hospitals, in the fields of blood, tumors, genetics, cardiovascular, cerebrovascular, infectious diseases, autoimmune diseases, etc., and by cooperating with the world's top medical technology institutions and large pharmaceutical companies Research services.

Company Profile

Symbol09960
Company NameKINDSTAR GLOBAL
ISINKYG5262E1044
Listing DateJul 16, 2021
Issue Price9.78
Shares Offered226.41M share(s)
FoundedAug 24, 2007
Registered AddressCayman Islands
Chairmanshiang huang
Secretaryhaijielimeiyi chai
Audit InstitutionErnst & Young
Company CategoryOverseas registration of Mainland Individuals control
Registered OfficeP.O. Box 472, 2nd Floor Harbour Place, 103 South Church Street George Town, Grand Cayman KY1-1106 Cayman Islands
Head Office and Principal Place of Business5/F, Manulife Plaza, 348 Kwun Tong Road, Kowloon, Hong Kong
Fiscal Year Ends12-31
Employees3125
MarketHong Kong motherboard
Phone(86)4007361666
Fax(86)4007361666
Emailpr@kindstar.com.cn
Business Kangsheng Global Genetic Technology Co., Ltd. is a Chinese investment holding company that mainly provides clinical testing services. The company operates nine business segments. The hematological testing department includes testing services related to blood diseases. The Genetic and Rare Diseases Department includes testing services for rare diseases. The Infectious Diseases Department includes testing services provided by the Infectious Diseases Department. The oncology department includes tests related to oncological diseases. The neurology department includes testing services for neurological diseases carried out by the group. The Department for Gynecology-Related Diseases includes gynaecology-related testing services. The COVID-19-related testing department includes COVID-19-related testing services. The Routine Testing Division carries out routine tests for physicians' routine diagnosis. Other departments include testing services for R&D projects and other services.

Company Executives

  • Name
  • Position
  • Salary
  • shiang huang
  • CEOs,Chief Medical Officer,presidencies,Executive Director,Chairman of the Nomination Committee
  • --
  • zanbing tu
  • Chief Operating Officer,Executive Director,Remuneration Committee Members
  • --
  • haijie chai
  • chief financial officer,Executive Director,Director of Wuhan Kangshengda, Kangsheng Investment and Wuhan Haixi,Joint Company Secretary,Authorized Representative
  • --
  • ruijin huang
  • Non-executive directors,Audit Committee Members
  • --
  • wei peng
  • Non-executive directors
  • --
  • lu huang
  • Non-executive directors
  • --
  • shanglong yao
  • Independent Non-Executive Director,Nomination Committee Members
  • --
  • xinping xia
  • Independent Non-Executive Director,Chairman of the Audit Committee,Nomination Committee Members,Remuneration Committee Members
  • --
  • huaming gu
  • Independent Non-Executive Director,Remuneration Committee Chairman,Audit Committee Members
  • --
  • meiyi li
  • Joint Company Secretary,Authorized Representative
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg